GWM
BHVN icon

Geneos Wealth Management’s Biohaven BHVN Stock Holding History

Geneos Wealth Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-69
Closed -$1.66K – 3121
2025
Q1 		$1.66K Buy
69
+46
+200% +$1.62K ﹤0.01% 2998
2024
Q4 		$859 Buy
+23
New +$1.07K ﹤0.01% 2804

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Geneos Wealth Management's BHVN Position: Q2 2025 in Review

Geneos Wealth Management sold out of Biohaven (BHVN) in Q2 2025, closing a stake of 69 shares — an estimated $1.66K sold.

Geneos Wealth Management first reported a position in BHVN in Q4 2024 and held it in 2 quarters. The position peaked at $1.66K in Q1 2025. 249 funds tracked by Wall St. Rank hold BHVN as of Q2 2025.

  • Geneos Wealth Management reported no remaining Biohaven position as of Q2 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 69 Biohaven shares in Q2 2025, an estimated $1.66K.
  • Geneos Wealth Management first reported a position in Biohaven in Q4 2024 and held it in 2 quarters.
  • Geneos Wealth Management's Biohaven position peaked at $1.66K in Q1 2025.
  • 249 funds tracked by Wall St. Rank held Biohaven as of Q2 2025.

Based on Geneos Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.